BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 17987059)

  • 1. BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia.
    Zhang XY; Zhou DF; Wu GY; Cao LY; Tan YL; Haile CN; Li J; Lu L; Kosten TA; Kosten TR
    Neuropsychopharmacology; 2008 Aug; 33(9):2200-5. PubMed ID: 17987059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.
    Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Ohta K; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aono M; Kameoka N; Sumitani S; Tomotake M; Kaneda Y; Taniguchi T; Ishimoto Y; Ohmori T
    Neurosci Lett; 2006 Jun; 401(1-2):1-5. PubMed ID: 16533563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the BDNF Val66Met polymorphism with BMI in chronic schizophrenic patients and healthy controls.
    Fang H; Zhen YF; Liu XY; Xu G; Soares JC; Zhao J; Zhang XY
    Int Clin Psychopharmacol; 2016 Nov; 31(6):353-7. PubMed ID: 27483421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics.
    Zhang XY; Tan YL; Zhou DF; Cao LY; Wu GY; Xu Q; Shen Y; Haile CN; Kosten TA; Kosten TR
    J Psychiatr Res; 2007 Dec; 41(12):997-1004. PubMed ID: 17095017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of genetic variation across IL-1β, IL-2, IL-6, and BDNF in antipsychotic-induced weight gain.
    Fonseka TM; Tiwari AK; Gonçalves VF; Lieberman JA; Meltzer HY; Goldstein BI; Kennedy JL; Kennedy SH; Müller DJ
    World J Biol Psychiatry; 2015 Jan; 16(1):45-56. PubMed ID: 25560300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-derived neurotrophic factor levels and its Val66Met gene polymorphism predict tardive dyskinesia treatment response to Ginkgo biloba.
    Zhang XY; Zhang WF; Zhou DF; Chen DC; Xiu MH; Wu HR; Haile CN; Kosten TA; Kosten TR
    Biol Psychiatry; 2012 Oct; 72(8):700-6. PubMed ID: 22695185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone-related weight gain: genetic and nongenetic predictors.
    Lane HY; Liu YC; Huang CL; Chang YC; Wu PL; Lu CT; Chang WH
    J Clin Psychopharmacol; 2006 Apr; 26(2):128-34. PubMed ID: 16633140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients.
    Hashim HM; Fawzy N; Fawzi MM; Karam RA
    J Psychiatr Res; 2012 Jun; 46(6):762-6. PubMed ID: 22521161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of brain-derived neurotrophic factor (BDNF) gene variants in antipsychotic response and antipsychotic-induced weight gain.
    Zai GC; Zai CC; Chowdhury NI; Tiwari AK; Souza RP; Lieberman JA; Meltzer HY; Potkin SG; Müller DJ; Kennedy JL
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):96-101. PubMed ID: 22642961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia.
    Koolschijn PC; van Haren NE; Bakker SC; Hoogendoorn ML; Hulshoff Pol HE; Kahn RS
    Hippocampus; 2010 Sep; 20(9):1010-7. PubMed ID: 19714565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients.
    Hong CJ; Yu YW; Lin CH; Tsai SJ
    Neurosci Lett; 2003 Oct; 349(3):206-8. PubMed ID: 12951204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics.
    Tan YL; Zhou DF; Cao LY; Zou YZ; Zhang XY
    Neurosci Lett; 2005 Jul 1-8; 382(1-2):27-32. PubMed ID: 15911116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BDNF val66met polymorphism is associated with age at onset and intensity of symptoms of paranoid schizophrenia in a Polish population.
    Suchanek R; Owczarek A; Paul-Samojedny M; Kowalczyk M; Kucia K; Kowalski J
    J Neuropsychiatry Clin Neurosci; 2013; 25(1):88-94. PubMed ID: 23487199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
    Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association of antipsychotic agent-induced weight gain with a polymorphism of the promotor region of the 5-HT2C receptor gene].
    Zhang Z; Zhang X; Yao Z; Chen J; Sun J; Yao H; Hou G; Zhang X; Reynolds GP
    Zhonghua Yi Xue Za Zhi; 2002 Aug; 82(16):1097-101. PubMed ID: 12425817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between BDNF levels and risperidone-induced weight gain is dependent on the BDNF Val66Met polymorphism in antipsychotic-naive first episode schizophrenia patients: a 12-week prospective study.
    Liu J; Wang P; Sun L; Guan X; Xiu M; Zhang X
    Transl Psychiatry; 2021 Sep; 11(1):458. PubMed ID: 34482368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BDNF Val66Met polymorphism is associated with body mass index in healthy adults.
    Gunstad J; Schofield P; Paul RH; Spitznagel MB; Cohen RA; Williams LM; Kohn M; Gordon E
    Neuropsychobiology; 2006; 53(3):153-6. PubMed ID: 16707914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No association of antipsychotic agent-induced weight gain with a DA receptor gene polymorphism and therapeutic response.
    Zhang ZJ; Yao ZJ; Zhang XB; Chen JF; Sun J; Yao H; Hou G; Zhang XB
    Acta Pharmacol Sin; 2003 Mar; 24(3):235-40. PubMed ID: 12617772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BDNF Val66Met polymorphism and anxiety/depression symptoms in schizophrenia in a Chinese Han population.
    Sun MM; Yang LM; Wang Y; Feng X; Cui KY; Liu LF; Chen ZY
    Psychiatr Genet; 2013 Jun; 23(3):124-9. PubMed ID: 23532065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment.
    Pirildar S; Gönül AS; Taneli F; Akdeniz F
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):709-13. PubMed ID: 15276697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.